Kirstie K. Danielson, PhD is an Associate Professor of Endocrinology, Diabetes & Metabolism and Epidemiology & Biostatistics. She received her PhD in Epidemiology from the University of Wisconsin-Madison; and completed postdoctoral training in Endocrinology at the University of Chicago, and Epidemiology at UIC. Dr. Danielson’s expertise as an epidemiologist is in the area of type 1 diabetes (T1D), specifically complications of the disease and therapies for T1D, along with biostatical approaches for large cohort and clinical trial studies. Her previous research has investigated the epidemiology of osteoporosis, cardiovascular disease, and altered reproductive function in patients both living with T1D and after being functionally cured of T1D by islet cell transplantation. And conversely, the impact of bone hormones, vascular function, and estrogen/sex differences on the ability of islet cell transplant to functionally cure T1D. Dr Danielson is internationally recognized for her work in the area of islet cell transplant as a functional cellular cure for T1D, and leads the UIC clinical research team on the first Biologics License Application to the FDA to make islet cell transplant part of standard of care in the U.S. She has been funded by NIH, the CDC, the American Diabetes Association, UIC, foundations, and industry. Dr Danielson has received several research awards and high praise for her teaching and mentoring, directly supervising dozens of students to date in diabetes research at UIC, and is frequently selected for national and international presentations of her work. She developed and teaches one of the most popular Honors College seminars at UIC on Current Perspectives in Diabetes and Treatments.
Luu QF, Villareal CJ, Fritschi C, Monson RS, Oberholzer J, Danielson KK. Concerns and hopes of patients with type 1 diabetes prior to islet cell transplantation: a content analysis. J Diabetes Complications 2018; 32: 677-81. PMCID: PMC6015784
Rydzon B, Monson RS, Oberholzer J, Varady KA, Bellin MD, Danielson KK. Long term (4 years) improved insulin sensitivity following islet cell transplant in type 1 diabetes. Diabetes Metab Res Rev 2018; 34: e2972. PMCID: PMC5873303
Madrigal JM, Monson RS, Hatipoglu B, Oberholzer J, Kondos GT, Varady KA, Danielson KK. Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes. Clin Transplant 2017; 31: e13059. PMCID: PMC5633499
Hassan LS, Monson RS, Danielson KK. Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls. Diabetes Metab Res Rev 2017; 33: e2829. PMCID: PMC5124523
Marchese E, Rodeghier C, Monson RS, McCracken B, Shi T, Schrock W, Martellotto J, Oberholzer J, Danielson KK. Enumerating β-cells in whole human islets: sex differences and associations with clinical outcomes after islet transplantation. Diabetes Care 2015; 38: e176-e177. PMCID: PMC4613918
Kujath AS, Quinn L, Elliott ME, LeCaire TJ, Binkley N, Molino AR, Danielson KK. Different health behaviors and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes. Diabetes Metab Res Rev 2015; 31: 421-32. PMCID: PMC4406845
Kujath AS, Quinn L, Elliott ME, Varady KA, LeCaire TJ, Carter CS, Danielson KK. Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared to matched controls. Diabetes Metab Res Rev 2015; 31: 102-12. PMCID: PMC4286520